Skip to main content

Together we are beating cancer

Donate now

Tim Gunn

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.
Showing 12 out of 64 results
Dr Yin Cao and a colleague looking at data about cancer incidence.

Rising rates of early-onset bowel cancer are a “global phenomenon”, and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon”, and some of the steepest increases are happening in England, according to a major new paper we helped fund.

by Tim Gunn | News | 11 December 2024

11 December 2024

A cancer cell dividing.

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

by Tim Gunn | News | 6 December 2024

6 December 2024

The capsule sponge shown in pill form and sponge form. Both are black and attached to a white thread.

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

by Tim Gunn | Analysis | 28 November 2024

28 November 2024

Two Cancer Research UK researchers working at a lab bench.

We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer. We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer.

by Tim Gunn | News | 20 November 2024

20 November 2024

Healthy lungs drawn as if they were an upside-down tree.

Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more. Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more.

by Tim Gunn | News | 14 November 2024

14 November 2024

broken cigarette on yellow background

Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years. Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years.

by Tim Gunn | News | 12 November 2024

12 November 2024

Colourful lollipops on a pink background.

Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably. Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably.

by Yvonne Ijeh, Tim Gunn | Analysis | 25 October 2024

25 October 2024

This entry is part 2 of 2 in the series Stand Up To Cancer research
A radiotherapy machine in a hospital. It is tilted to show how it can move to target tumours.

A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies.  A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies. 

by Tim Gunn | News | 7 October 2024

7 October 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Two women seated in a hospital waiting room

With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance.  With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance. 

by Tim Gunn | News | 20 September 2024

20 September 2024

Tesco pharmacists wearing Cancer Research UK-branded
  • Health & Medicine
  • Charity News

Tesco pharmacies are helping spot cancer early

For the September early diagnosis campaign, Tesco customers with unusual symptoms or questions about cancer are invited to get expert information and support while they shop. For the September early diagnosis campaign, Tesco customers with unusual symptoms or questions about cancer are invited to get expert information and support while they shop.

by Tim Gunn | News | 18 September 2024

18 September 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024